Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R.
J Clin Endocrinol Metab. 2023 Aug 18;108(9):2400-2423. doi: 10.1210/clinem/dgad174.
PMID:36974474
Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.
Kanai Y.
Pharmacol Ther. 2022 Feb;230:107964. doi: 10.1016/j.pharmthera.2021.107964. Epub 2021 Aug 12.
PMID:34390745
[Prolactinoma].
Glezer A, Bronstein MD.
Arq Bras Endocrinol Metabol. 2014 Mar;58(2):118-23. doi: 10.1590/0004-2730000002961.
PMID:24830588
Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas.
Raverot G, Burman P, Abreu AP, Heaney AP, van Hulsteijn L, Lin AL, Marcus H, McCormack A, Minniti G, Petersenn S, Popovic V, Theodoropoulou M, Trouillas J, Dekkers OM.
Eur J Endocrinol. 2025 May 30;192(6):R45-R78. doi: 10.1093/ejendo/lvaf100.
PMID:40506054
Prolactinomas.
Katznelson L, Klibanski A.
Cancer Treat Res. 1997;89:41-55. doi: 10.1007/978-1-4615-6355-6_3.
PMID:9204187
Activin A in Mammalian Physiology.
Bloise E, Ciarmela P, Dela Cruz C, Luisi S, Petraglia F, Reis FM.
Physiol Rev. 2019 Jan 1;99(1):739-780. doi: 10.1152/physrev.00002.2018.
PMID:30540228
Rhabdoid Tumor Predisposition Syndrome.
Nemes K, Bens S, Bourdeaut F, Johann P, Kordes U, Siebert R, Frühwald MC.
2017 Dec 7 [updated 2022 May 12]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.